Kolexia
Dumortier Jerome Gastro-entérologie
Dumortier Jerome
Gastro-entérologie
Hôpital Edouard Herriot
Lyon, France
363 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose Hépatite Cirrhose du foie Maladies du foie Carcinome hépatocellulaire Tumeurs du foie Hépatite C Carcinomes Complications postopératoires

Collaborateurs

Voir plus
Guillaud Olivier
Guillaud Olivier
Clinique Du Val D'ouest Vendome, Écully, France
Boillot Olivier
Boillot Olivier
Hôpital Edouard Herriot, Lyon, France
Pageaux Georges-Philippe
Pageaux Georges-Philippe
Hôpital Saint-Éloi, Montpellier, France
Radenne Sylvie
Radenne Sylvie
Hôpital La Croix-Rousse, Lyon, France

Industries

Voir plus
B3TSI
42 collaboration(s)
Dernière en 2023
A+A
26 collaboration(s)
Dernière en 2023
Biotest
15 collaboration(s)
Dernière en 2023
Astellas
14 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
PRO-SURFASA: Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis, a National Prospective Multicentre Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   11 mars 2024
Recipient age influences survival after liver transplant: Results of the French national cohort 2007-2017.
Liver international : official journal of the International Association for the Study of the Liver   07 mars 2024
Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development.
Liver international : official journal of the International Association for the Study of the Liver   29 février 2024
Characteristics, management, and outcome of tuberculosis after liver transplant: A case series and literature review.
Infectious diseases now   23 février 2024
Conversion from twice-daily everolimus to once-daily sirolimus in long-term stable liver transplant recipients.
Transplant immunology   21 février 2024
Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 96 weeks: a retrospective multicenter european study (SAVE-D)
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
Frontiers in immunology   24 janvier 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
Frontiers in immunology   10 janvier 2024
A biliary cast syndrome requiring liver transplantation: an original sequence.
Journal of gastrointestinal and liver diseases : JGLD   22 décembre 2023